Learn more

ADVANCED ACCELERATOR APPLICATIONS ITALY SRL

Overview
  • Total Patents
    16
  • GoodIP Patent Rank
    105,530
About

ADVANCED ACCELERATOR APPLICATIONS ITALY SRL has a total of 16 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Taiwan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PERIOC LTD, MOONSHOT PHARMA LLC and BEXION PHARMACEUTICALS INC.

Patent filings in countries

World map showing ADVANCED ACCELERATOR APPLICATIONS ITALY SRLs patent filings in countries
# Country Total Patents
#1 WIPO (World Intellectual Property Organization) 10
#2 United States 5
#3 Taiwan 1

Patent filings per year

Chart showing ADVANCED ACCELERATOR APPLICATIONS ITALY SRLs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Fugazza Lorenza 13
#2 Barbato Donato 12
#3 Chicco Daniela 11
#4 De Palo Francesco 10
#5 Tesoriere Giovanni 10
#6 Brambati Clementina 10
#7 Mariani Maurizio 8
#8 Mariani Maurizio F 8
#9 Orlandi Francesca 5
#10 Tedesco Mattia 2

Latest patents

Publication Filing date Title
WO2021058549A1 Radiolabelled grpr-antagonist for use as theragnostic
WO2021053040A1 Methods for radiolabelling grpr antagonists and their kits
WO2021052960A1 Stable, concentrated radiopharmaceutical composition
WO2021001360A1 Prostate specific membrane antigen (psma) ligands and uses thereof
WO2021001362A1 Prostate specific membrane antigen (psma) ligands and uses thereof
WO2020064693A1 Combination therapy
TW202019489A Stable, concentrated radionuclide complex solutions
WO2020088767A1 Methods for synthesis of radionuclide complex
US2020030464A1 Stable, concentrated radionuclide complex solutions
US2020030467A1 Stable, concentrated radionuclide complex solutions
US2020030466A1 Stable, concentrated radionuclide complex solutions
WO2020021322A1 Stable, concentrated radionuclide complex solutions
WO2020021310A1 Stable, concentrated radionuclide complex solutions
US2020030465A1 Stable, concentrated radionuclide complex solutions